MedTrace Logo

The Effects of Virtual Reality and Music on Pain, Anxiety, Itching, and Vital Signs

NCT06479967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-07-01

No results posted yet for this study

Summary

Aim: This study aimed to examine the effects of virtual reality and music on pain, anxiety, itching, and vital signs of children during a skin prick test and evaluation.

Background:Virtual reality and music are utilised to reduce pain, anxiety, and itching in children throughout various treatment processes.

Methods: This randomised controlled trial was divided into three groups: Virtual reality (n=30), music (n=30), and control (n=30). Anxiety was assessed before and after the skin prick test using the "State-Trait Anxiety Inventory for Children"; pain was assessed during and after the skin prick test using the "Wong-Baker Faces Pain Rating Scale"; vital signs were measured before, during, and after the skin prick test, and the itch assessment "Visual Analogue Score" was assessed at 5, 10, and fifteen minutes after the skin prick test. The study followed the CONCORT guideline.

Conditions

Interventions

OTHER

The VR glasses group

The Virtual Reality glasses group watched a cartoon video of \"Rafadan Tayfa Gizli Hazine" The VR glasses group watched a cartoon video of \"Rafadan Tayfa Gizli Hazine" After the SPT, the VR glasses group took a 1-minute break from watching videos and the child\'s pain was assessed with WBFPS. During the 15-minute SPT assessment, the VR glasses group continued watching cartoon

OTHER

the music group

The music group listened to classical piano \"The Best of Chopin.\" After the music group took a 1-minute break from listening to music, and the child\'s pain was assessed with WBFPS. During the 15-minute SPT assessment, the music group continued to listen to the music. During the SPT evaluation, the music group took a 1-minute break from listening to music at 5, 10, and 15 minutes, and the child evaluated the level of itching from 1 to 10.

Sponsors & Collaborators

  • Uludag University

    lead OTHER

Principal Investigators

  • Eda UNAL, PhD · Uludag universty

  • Aysel OZDEMIR, PhD · Uludag University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-12
Primary Completion
2023-06-15
Completion
2023-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06479967 on ClinicalTrials.gov